Loading…
← CockpitCompetitor Analysis › JLHL.NS Jupiter Life Line Hospitals Ltd.Open in the cockpit ↗

Jupiter Life Line Hospitals Ltd.JLHL.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Hospital/Nursing Management
Momentum strong 67
Mkt cap
$1.01B
US dollars, full cap
Free float
34%
of shares outstanding
$/day
$290,441
20-day average traded
Fwd P/E
48.8×
forward earnings
ROIC−WACC
-1.6 pp
WACC 11.9%
Hurdle
n/a
no reverse DCF
Next earnings
79 days
5 Feb 2027
Close · INR₹289.60
1D-0.1%
1W+1.1%
1M+18.7%
3M-9.0%
6M+9.0%
YTD+3.9%
1Y-2.6%
ATR %3.5%
Beta0.30
52w lowhigh14.8% off high

What Jupiter Life Line Hospitals does

Employees: 4,947

Jupiter Life Line Hospitals at a glance

Size Jupiter Life Line Hospitals (JLHL.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $1.01B, the 592nd largest of 1,066 India companies the cockpit tracks. Shares closed at ₹289.60 on 18 Nov 2026.

Performance Over six months the shares gained 9.0%, against -3.8% for the median peer and +3.8% for the India market (cap-weighted) — 7th highest of 20 in its peer set.

Growth Revenue grew 16.7% over the last twelve months (peer median +13.8%); the operating margin is 16.0% (peer median 10.3%).

Valuation It trades at 48.8× forward earnings against a peer median of 30.6× (5th most expensive of 16).

Capital Return on invested capital runs 1.6 points below its cost of capital (11.9% WACC).

Next results Next results expected around 5 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026JLHL.NS 110Peer median 94
Six months, rebased to 100: Jupiter Life Line Hospitals against the median of its 20 peers (local-currency closes).

Jupiter Life Line Hospitals financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹16.2B₹15.0B₹13.0B₹10.7B₹8.93B
Revenue growth—+15%+22%+20%—
Gross profit₹9.24B₹7.85B₹6.89B₹6.23B₹5.20B
EBITDA₹3.59B₹3.48B₹3.09B₹2.41B₹2.03B
Net income₹1.86B₹1.94B₹1.93B₹1.75B₹729M
Free cash flown/a-₹2.34B-₹490M₹264M₹597M
Capital expendituren/a₹5.02B₹3.28B₹853M₹772M
Total debt₹6.69B₹5.84B₹3.93B₹0₹4.69B

Quarterly statements and history in the cockpit →

Jupiter Life Line Hospitals competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-10%0%+10%+20%CBAVRHKGDSHCGPARKHOSPSA50YATHARTHCVSGBSLSPI301293KOVAIRAINBOWAEVSARTEMISMED301267EXEJLHL.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Jupiter Life Line Hospitals is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%50×100×CBAVRHKHCGPARKHOSPSYATHARTHCVSGBSL301293RAINBOWAEVSSIAARTEMISMEDEXEJLHL.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Jupiter Life Line Hospitals is the large dot.

Jupiter Life Line Hospitals competitors and peer comparison

How Jupiter Life Line Hospitals compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Jupiter Life Line Hospitals against its 20 peers (data as of 18 Nov 2026)
MeasureJLHL.NSPeer medianRank in peer set
1-month return+18.7%+1.6%highest of 20
6-month return+9.0%-3.8%7th highest of 20
Distance from 52-week high-14.8%-18.4%10th highest of 21
Revenue growth (TTM)+16.7%+13.8%7th highest of 21
Operating margin16.0%10.3%5th highest of 21
Forward P/E48.8×30.6×5th most expensive of 16
ROIC minus cost of capital-1.6 pp-2.7 pp9th highest of 21
EV / EBITDA27.1×18.3×4th most expensive of 16
Net debt / EBITDA0.7×2.1×7th least indebted of 17

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
Yatharth Hospital and Trauma Care Services YATHARTH.NSIndia$1.13B+31%+50%16%49.4×n/an/a
CVS CVSG.LUnited Kingdom$1.22B+17%+6%11%14.6×14.2%+6.9%
Raffles Medical BSL.SISingapore$1.23B-13%-3%11%27.1×-2.7%+6.1%
Spire Healthcare SPI.LUnited Kingdom$1.31B+11%+2%8%25.1×10.0%+11.4%
Sanbo Hospital Management 301293.SZChina$1.35B-29%+17%6%135.5×n/an/a
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Rainbow Childrens Medicare RAINBOW.NSIndia$1.37B-7%+23%22%40.4×30.7%+21.2%
Aevis Victoria AEVS.SWSwitzerland$1.43B+8%+15%-6%106.8×26.5%+10.2%
Xi'an International Medical Investment 000516.SZChina$1.46B-2%-1%-2%n/a12.7%+20.6%
Sienna Senior Living SIA.TOCanada$1.58B-8%+15%10%40.9×18.9%+8.6%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%
Huaxia Eye Hospital 301267.SZChina$1.78B-18%+2%15%23.5×2.1%+10.4%
Extendicare EXE.TOCanada$1.91B-16%+36%9%19.3×10.8%+8.5%

Questions

Which companies are Jupiter Life Line Hospitals's closest peers?
The cockpit's peer set: Clinica Baviera (CBAV.MC), Rhon-klinikum (RHK.DE), Ramsay Generale de Sante (GDS.PA), Paras Healthcare (PARASHLTH.NS), HealthCare Global Enterprises (HCG.NS), Park Medi World (PARKHOSPS.NS), Thomson Medical (A50.SI), Yatharth Hospital and Trauma Care Services (YATHARTH.NS).
Is Jupiter Life Line Hospitals expensive compared with its peers?
On forward p/e it trades at 48.8× against a peer median of 30.6×, 5th most expensive of 16 in its peer set.
How has Jupiter Life Line Hospitals stock performed?
Over six months to 18 Nov 2026 the shares returned +9.0% against -3.8% for the median peer; over one year -2.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.